Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Devacell Inc
Profile last edited on: 5/18/2023      CAGE: 6NTG2      UEI:

Business Identifier: Enzymatic therapies to treat multiple diseases
Year Founded
2012
First Award
2014
Latest Award
2014
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

6650 Lusk Boulevard Suite B105
La Jolla, CA 92121
   (858) 699-4775
   info@devacell.com
   devacell.com
Location: Single
Congr. District: 52
County: San Diego

Public Profile

DevaCell’s novel enzyme nano-encapsulation technology shields enzymes of non-human origin from the immune system. This enables a platform of enzymatic therapies to treat multiple diseases including most cancers and refractory gout.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$224,900
Phase II Dollars
$0
Total Awarded
$224,900

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2014 1 NIH $224,900
Project Title: Methioninase Loaded Nanoshells for Systemic Methionine Depletion Therapy

Key People / Management

  Sadik Esener -- Chairman Of The Scientific Advisory Board

  Inanc Ortac -- Chief Technology Officer

  Ibrahim (Abe) Gokce Yayla -- Chief Executive Officer

Company News

There are no news available.